Ausgabe 5/2020
Including Invited Reviews on PD-1 blockade cancer immunotherapy
Inhalt (26 Artikel)
Toward a new stage of PD-1 blockade cancer immunotherapy
Nagahiro Minato
Current issues and perspectives in PD-1 blockade cancer immunotherapy
Kenji Chamoto, Ryusuke Hatae, Tasuku Honjo
Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
Hiro Sato, Noriyuki Okonogi, Takashi Nakano
Immune-resistant mechanisms in cancer immunotherapy
Yutaka Kawakami, Shigeki Ohta, Mohammad A. Sayem, Nobuo Tsukamoto, Tomonori Yaguchi
Combination therapy with PD-1 or PD-L1 inhibitors for cancer
Hidetoshi Hayashi, Kazuhiko Nakagawa
Faithful preclinical mouse models for better translation to bedside in the field of immuno-oncology
Ryoichi Saito, Takashi Kobayashi, Soki Kashima, Keiyu Matsumoto, Osamu Ogawa
Treatment strategies for neuroendocrine carcinoma of the upper digestive tract
Masaru Morita, Kenichi Taguchi, Masaki Kagawa, Tomonori Nakanoko, Hideo Uehara, Masahiko Sugiyama, Mitsuhiko Ota, Masahiko Ikebe, Keishi Sugimachi, Taito Esaki, Yasushi Toh
Magnitude of advantage in tumor response contributes to a better correlation between treatment effects on overall survival and progression-free survival: a literature-based meta-analysis of clinical trials in patients with metastatic colorectal cancer
Yosuke Yoshida, Masayuki Kaneko, Mamoru Narukawa
A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75 years or more with advanced non-small cell lung cancer -TCOG 1101-
Takashi Kasai, Kiyoshi Mori, Kazuma Kishi, Takayuki Kaburagi, Yukio Hosomi, Hisao Imai, Yutaka Yamada, Makiko Yomota, Syuhei Moriguchi, Masahiro Seike, Koichi Minato, Akihiko Gemma
Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma
Naoki Ozeki, Koji Kawaguchi, Takayuki Fukui, Shota Nakamura, Shuhei Hakiri, Shunsuke Mori, Masaki Goto, Shingo Iwano, Kohei Yokoi, Toyofumi Fengshi Chen-Yoshikawa
Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution
Toshio Takagi, Kazuhiko Yoshida, Arisa Wada, Tsunenori Kondo, Hironori Fukuda, Hiroki Ishihara, Hirohito Kobayashi, Junpei Iizuka, Masayoshi Okumi, Hideki Ishida, Yoji Nagashima, Kazunari Tanabe
Prognostic outcomes and safety in patients treated with pembrolizumab for advanced urothelial carcinoma: experience in real-world clinical practice
Daichi Tamura, Noriaki Jinnouchi, Masakazu Abe, Daiki Ikarashi, Tomohiko Matsuura, Renpei Kato, Shigekatsu Maekawa, Yoichiro Kato, Mitsugu Kanehira, Ryo Takata, Wataru Obara
Barriers for sperm cryopreservation in advanced germ cell tumor patients: a 20-year experience
Katsuhiro Ito, Kentaro Ichioka, Sachiko Dahal, Yoshiyuki Matsui, Takahiro Nakayama, Hiroshi Hatayama, Osamu Ogawa, Hiromitsu Negoro
Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan
Shintaro Narita, Shingo Hatakeyama, Masahiro Takahashi, Toshihiko Sakurai, Sadafumi Kawamura, Senji Hoshi, Masanori Ishida, Toshiaki Kawaguchi, Shigeto Ishidoya, Jiro Shimoda, Hiromi Sato, Atsushi Koizumi, Koji Mitsuzuka, Tatsuo Tochigi, Norihiko Tsuchiya, Chikara Ohyama, Yoichi Arai, Kyoko Nomura, Tomonori Habuchi
Outcome of patients with primary retroperitoneal solitary fibrous sarcoma
Peng Luo, Zhiqiang Wu, Shiqi Chen, Lingge Yang, Weiluo Cai, Yong Chen, Wangjun Yan, Chunmeng Wang
Clinical characteristics and surgical outcomes of retroperitoneal tumors: a comprehensive data collection from multiple departments
Naoto Sassa, Yukihiro Yokoyama, Yoshihiro Nishida, Suguru Yamada, Hiroo Uchida, Hiroaki Kajiyama, Masato Nagino, Yasuhiro Kodera, Momokazu Gotoh
Laparoscopic versus abdominal radical hysterectomy for stage IB1 cervical cancer patients with tumor size ≤ 2 cm: a case-matched control study
Chunlin Chen, Ping Liu, Yan Ni, Lian Tang, Yan Xu, Xiaonong Bin, Jinghe Lang
Operation for locally advanced cervical cancer after concurrent chemoradiotherapy
Junli Ge, Jidong Sun, Jia Li, Qianfeng Zhang, Xiaohui Lv, Biliang Chen
Postradiotherapy persistent lymphopenia as a poor prognostic factor in patients with cervical cancer receiving radiotherapy: a single-center, retrospective study
Ayumi Taguchi, Akiko Furusawa, Kei Ito, Yujiro Nakajima, Takuya Shimizuguchi, Konan Hara, Maki Takao, Tomoko Kashiyama, Nao Kino, Katsuyuki Karasawa, Toshiharu Yasugi
Risk factors for lower limb lymphedema in gynecologic cancer patients after initial treatment
Teruyo Kunitake, Tatsuyuki Kakuma, Kimio Ushijima
Multicenter prospective phase II trial of nivolumab in patients with unresectable or metastatic mucosal melanoma
Motoo Nomura, Isao Oze, Toshiki Masuishi, Tomoya Yokota, Hironaga Satake, Shunichiro Iwasawa, Ken Kato, Masashi Andoh
Safety of radiotherapy for hemodialysis patients with cancer
Hiroshi Hirota, Kei Ito, Shun-Ichiro Kageyama, Fumihiko Tamamoto, Katsuyuki Karasawa, Ryouichi Yoshimura
High-grade complication is associated with poor overall survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Joey Wee-Shan Tan, Grace Hwei Ching Tan, Wai Yee Ng, Chin-Ann Johnny Ong, Claramae Shulyn Chia, Khee Chee Soo, Melissa Ching Ching Teo